You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
Skip Main Navigation
Skip All Navigation
Albany Law Journal of Science and Technology
Too Costly to Defend: Who Is Benefited From the U.S. Supreme Court’s Recent Holdings Concerning Biotechnology Patent Disputes?
18.0000000000000 ALB. L.J. SCI. & TECH. 53 (2008)
Yi-Chen Su, Albert Wai-Kit Chan
Justice Scalia’s recent holdings on behalf of the Supreme Court in Merck KGaA v. Integra Lifesciences I, Ltd. and MedImmune Inc. v. Genentech, Inc. have had a grave impact on biotechnology research. These cases represent the two sides of the same coin and, therefore, should be examined together rather than separately.